Semaglutide News

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity - GOV.UK

Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity GOV.UK

Canadian lab explains puzzling link between semaglutide, better liver health - The Globe and Mail

Canadian lab explains puzzling link between semaglutide, better liver health The Globe and Mail

Stanford scientists discover “natural Ozempic” without side effects - ScienceDaily

Stanford scientists discover “natural Ozempic” without side effects ScienceDaily

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide - PR Newswire

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide PR Newswire

Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions - The Globe and Mail

Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions The Globe and Mail

Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study - SciTechDaily

Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study SciTechDaily

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests - ScienceAlert

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests ScienceAlert

India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top - CNBC

India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top CNBC

Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight - bbc.com

Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight bbc.com

Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - Reuters

Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy Reuters

Clinical trial results show weight loss drug reduces the risk of heart and liver diseases in people with obesity - VCU Health

Clinical trial results show weight loss drug reduces the risk of heart and liver diseases in people with obesity VCU Health

FDA Gives Tentative Approval of ANDA for Generic Semaglutide Injection - HCPLive

FDA Gives Tentative Approval of ANDA for Generic Semaglutide Injection HCPLive

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight - Medical Professionals Reference

Comparison of Oral Semaglutide (Wegovy) and Orforglipron (Foundayo) for the Treatment of Obesity and Overweight Medical Professionals Reference

GLP-1 Drug Improves Liver Health Independent of Weight Loss, Mouse Study Finds - Genetic Engineering and Biotechnology News

GLP-1 Drug Improves Liver Health Independent of Weight Loss, Mouse Study Finds Genetic Engineering and Biotechnology News

GLP-1 medicine improves liver health independent of weight loss - Sinai Health

GLP-1 medicine improves liver health independent of weight loss Sinai Health

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India - CNBC

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India CNBC

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial - Nature

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial Nature

India’s generic semaglutide surge - Chemistry World

India’s generic semaglutide surge Chemistry World

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway - KSL TV 5

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway KSL TV 5

FDA Tentatively Approves Generic Version of Semaglutide - Drug Topics

FDA Tentatively Approves Generic Version of Semaglutide Drug Topics

A VA Clinic Gave Veterans GLP-1s for Weight Loss. A Year Later, Everything Improved - Military.com

A VA Clinic Gave Veterans GLP-1s for Weight Loss. A Year Later, Everything Improved Military.com

Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular - PR Newswire

Apotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular PR Newswire

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide - PR Newswire